Results 81 to 90 of about 41,247 (202)

The race for Ebola drugs: pharmaceuticals, security and global health governance [PDF]

, 2016
The international Ebola response mirrors two broader trends in global health governance: (1) the framing of infectious disease outbreaks as a security threat; and (2) a tendency to respond by providing medicines and vaccines.
Anne Roemer-Mahler, Brower Jennifer, Burton Thomas M., Buzan Barry, Calhoun Craig, Clarke Adele, Collier Stephen J., Conrad Peter, Cooper Melinda, Elbe Stefan, Elbe Stefan, Enemark Christian, EU, Fearnley Lyle, Fidler David, Goldacre Ben, Healy David, Hirschler Ben, Hirschler Ben, Institute of Medicine, Kamradt-Scott Adam, Kieny Marie-Paule, Klein Betsy, Koch Erin, Lakoff Andrew, McInnes Colin, Moran Nuala, Nunes Joao, Paul Steven M., Petryna A., Rose Dale, Rushton Simon, Stefan Elbe, Stein Sam, Stroud Clare, US Department of Health and Human Services, US Department of Health and Human Services, US Food and Drug Administration, Weir Lorna, Weir Lorna, Wellcome Trust, and CIDRAP, WHO, Wintour Patrick   +42 more
core   +1 more source

Adenovirus-vectored Ebola vaccines

Expert Review of Vaccines, 2015
The 2014 outbreak of Ebola virus disease in West Africa has highlighted the need for the availability of effective vaccines against outbreak pathogens that are suitable for use in frontline workers who risk their own health in the course of caring for those with the disease, and also for members of the community in the affected area.
openaire   +2 more sources

Ebola vaccine, therapeutics, and diagnostics

Uirusu, 2016
Ebolaviruses, members of the family Filoviridae, cause severe hemorrhagic fever in humans and nonhuman primates, with human case fatality rates of up to 90%. No effective prophylaxis or treatment for Ebola virus disease (EVD) is yet commercially available.
Wakako, Furuyama, Ayato, Takada
openaire   +3 more sources

Healthcare Development, Relaxed Natural Selection, and COVID‐19 Infection Rates: An Evolutionary Population‐Level Analysis

Health Science Reports, Volume 9, Issue 3, March 2026.
ABSTRACT Background and Aim Evolutionary principles offer critical insights into pandemic dynamics but have been largely overlooked in contemporary responses to COVID‐19. Relaxed natural selection, increased global mobility, and lifestyle mismatches have contributed to human vulnerability to infectious diseases in modern societies.
Wenpeng You, Brendon Coventry, Arthur Saniotis, Francesco Maria Galassi, Renata Henneberg, Maciej Henneberg   +5 more
wiley   +1 more source

Effects of vaccines in protecting against Ebola virus disease: protocol for a systematic review

BMJ Open, 2019
Introduction Ebola virus disease is one of the most devastating infectious diseases in the world with up to 90% case fatality observed. There are at least 13 candidate vaccines developed and being tested to prevent the occurrence of the Ebola virus ...
Duduzile Edith Ndwandwe, Charles Shey Wiysonge, Lindi Mathebula, Elizabeth Pienaar   +3 more
doaj   +1 more source

Testing Modeling Assumptions in the West Africa Ebola Outbreak [PDF]

, 2016
The Ebola virus in West Africa has infected almost 30,000 and killed over 11,000 people. Recent models of Ebola Virus Disease (EVD) have often made assumptions about how the disease spreads, such as uniform transmissibility and homogeneous mixing within ...
Burghardt, Keith, Hasne, Marie-Pierre, Huang, Junming, Ingram, Matthew, Song, Binyang, Verzijl, Christopher   +5 more
core   +3 more sources

Critical Evaluation of the Impact of COVID‐19 Pandemic on Child Health and Wellbeing and Suggested Preparedness for Future Pandemics–A Narrative Review

Health Science Reports, Volume 9, Issue 3, March 2026.
ABSTRACT Background and Aims The immediate and long‐term effects of COVID‐19 pandemic on the children go beyond just being a viral infection. A child's mental health and psychological issues like irritability, anxiety, sadness, non‐attentiveness, attention deficit and hyperactive disorder needed evaluation.
Ranjan K. Mohapatra, Ashish K. Sarangi, Gurudutta Pattnaik, Puneet K. Singh, Rasmita Dash, Venkataramana Kandi, L. V. Simhachalam Kutikuppala, Rudra Narayan Sahoo, Snehasish Mishra, Anita Mishra, Sourya Subhra Nasker, Sasmita Nayak, Hayam A. Alrasheed, Nawal A. Al Kaabi, Amer Alshengeti, Altaf A. Abdulkhaliq, Ali A. Rabaan, Maha F. Al‐Subaie, Saad Alhumaid, Kuldeep Dhama, Md. Kudrat‐E‐Zahan   +20 more
wiley   +1 more source

“Beyond the Crisis: Forging a Climate‐Resilient Health System for Bangladesh”

Health Science Reports, Volume 9, Issue 3, March 2026.
ABSTRACT Background Bangladesh's extreme vulnerability to climate change is fueling public health emergencies, from infectious disease outbreaks to severe mental health burdens. The country's reactive and centralized health system is increasingly unable to cope with these intensifying shocks.
Abdullaha Al Mamun, Mustafa Sarwar A Kayenat   +1 more
wiley   +1 more source

In silico Designed Ebola Virus T-Cell Multi-Epitope DNA Vaccine Constructions Are Immunogenic in Mice

Vaccines, 2019
Background: The lack of effective vaccines against Ebola virus initiates a search for new approaches to overcoming this problem. The aim of the study was to design artificial polyepitope T-cell immunogens—candidate DNA vaccines against Ebola virus ...
Sergei I. Bazhan, Denis V. Antonets, Larisa I. Karpenko, Svetlana F. Oreshkova, Olga N. Kaplina, Ekaterina V. Starostina, Sergei G. Dudko, Sofia A. Fedotova, Alexander A. Ilyichev   +8 more
doaj   +1 more source

Driving improvements in emerging disease surveillance through locally-relevant capacity strengthening [PDF]

, 2017
Emerging infectious diseases (EIDs) threaten the health of people, animals, and crops globally, but our ability to predict their occurrence is limited. Current public health capacity and ability to detect and respond to EIDs is typically weakest in low ...
Cleaveland, Sarah, Halliday, Jo E.B., Hampson, Katie, Hanley, Nick, Haydon, Daniel T., Lembo, Tiziana, Sharp, Joanne P.   +6 more
core   +2 more sources